Chronic metabolic diseases
Conditions
Interventions
Case series:None
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. For Shenzhen residents aged 18 and above who seek medical treatments in social health institutions and voluntarily take blood glucose testing, meeting one of the following criteria: (1) Previous hemoglobin A1c (HbA1c)>= 5.7%, or impaired fasting glucose (IFG), or impaired glucose tolerance (IGT), or IGT+IFG; (2) Overweight [body mass index (BMI) >= 24 kg m-2] or obese (BMI >= 28 kg m-2) and/or central obesity (waist circumference >= 90 cm for men, and >= 85 cm for women), or have sedentary lifestyle (insufficient physical activity); (3) 35 years old and above; (4) Hypertension (or taking antihypertensive treatment currently), or hyperlipidemia (or taking lipid-lowering treatment currently), or high homocysteine (Hcy>=10umol/L), or history of cardiovascular diseases, or nonalcoholic fatty liver disease; (5) History of gestational diabetes or polycystic ovary syndrome (PCOS); (6) Family history of type 2 diabetes in first-degree relatives; (7) Those who have been treated with antipsychotics and/or antidepressants for a long time; 2. Type 2 diabetes patients (including outpatient and inpatient) or patients meeting the definition of a high-risk group of diabetes screened in clinical institutions; 3. Voluntarily and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Any disease diagnosed by investigators following the DSM-IV diagnostic criteria that may limit the compliance of participants or data collection; 2. Participants considered by investigators unsuitable for the study or long-term follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose control rate;Blood Pressure control rate;Blood homocysteine control rate;Incidence of kidney failure;Incidence of new-onset albuminuria; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of blood pressure;Changes of blood lipids;Changes of blood homocysteine;Changes of Blood uric acid;Changes of blood glucose;Changes of eGFR;Changes of albumin-to-creatinine ratio (ACR);Changes of albumin-to-creatinine ratio (ACR); | — |
Countries
China
Contacts
Public ContactYan Dewen
Shenzhen Second People's Hospital
Outcome results
None listed